About Demetrix
Demetrix is a Healthcare company based in Berkeley (United States) founded in 2017 by William A Haseltine and Jay Keasling. Cannabinoid ingredients for pharmaceuticals are produced via fermentation technology. Demetrix has raised $61 million across 2 funding rounds from investors including Tuatara Capital, Horizons Ventures and Li Ka-shing. The company has 77 employees. Its chief executive, as recorded, is Jeff Ubersax. Its focus areas include HealthTech, Cannabis HealthTech and Nutraceuticals. Its legal entity is DEMETRIX, INC. Its competitors include Vireo Health, Shopbeam and cbdMD.
Company details
Demetrix was founded in 2017 in Berkeley, United States, and operates within the biotechnology sector focused on cannabinoids. Rare, high-purity cannabinoid ingredients are developed and commercialized using fermentation technology for pharmaceutical and consumer health applications. Production processes are regulated to ensure compliance, with emphasis placed on wellness products derived from these ingredients. Operations are centered in the United States, supporting global commercialization efforts.
- Headquarters Berkeley, United States
- Employees 77
- Founders William A Haseltine, Jay Keasling
- SectorsHealthcare
- Email••••••••
- Website demetrix.com
- Social LinkedIn X
- Legal Name Demetrix, Inc.
- Total Equity Funding$61M (USD)
in 2 rounds
- Latest Funding Round$50M (USD), Series A
Jul 2019
- InvestorsTuatara Capital
& 2 more
- Employee Count77
Funding Insights of Demetrix
Demetrix has successfully raised a total of $61M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $50 million completed in July 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $61M
- Total Rounds 2
- Last Round Series A — $50M
- First Round $11M
(Jan 2018)
- Investors Count 3
All 2 funding rounds of Demetrix with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2019 | $50M | Series A | – | Tuatara Capital | |
| Jan 2018 | $11M | Seed | – | Horizons Ventures | – |
3 investors in total: 2 institutional and 1 angel.
Investors in Demetrix
Demetrix has secured backing from 3 investors, including venture fund and angel investors. Prominent investors backing the company include Tuatara Capital, Horizons Ventures and Li Ka-shing.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Horizons Ventures is focused on investing in deep science and technology. | horizonsventures.com | Hong Kong, China | ||
Private equity firm investing and cannabis-focused consumer and retail firms | 2014 | tuataracapital.com | New York, United States | |
LK Li Ka-shing | unknown_65283163180149f3a |
Investor details for Demetrix
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Demetrix
8 people are tracked at Demetrix (3 in leadership, 3 in board & advisors, 2 in team); the tracked headcount is 77.
| Name | Role | Group |
|---|---|---|
William A Haseltine | Co-Founder | Leadership |
Jay Keasling | Co-Founder | Leadership |
Jeff Ubersax | CEO | Leadership |
William Haseltine | Director | Board & advisors |
Marc Riiska | Director | Board & advisors |
Patrick Zhang | Director | Board & advisors |
Safa Toma | Manager, EH&S | Team |
Yuora Yelpaala | Scientist, Analytical Chemist | Team |
Complete people profiles for Demetrix
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Demetrix
3 dated milestones of Demetrix across 2 years, from founding to its latest funding, stage changes and deals.
- Founded Demetrix is founded.
- Funding First funding round of $11.0M.
- Funding Latest funding round, Series A, of $50.0M.
Competitors of Demetrix
Demetrix has 3 listed competitors in our database. They include Vireo Health, Shopbeam and cbdMD.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| vireohealth.com | 2004 | Minneapolis, United States | Cannabis plants are cultivated in greenhouses for wellness product development. | |||
| shopbeam.com | 2018 | Boston, United States | 16 | Provider of fine art photography prints and books | ||
| cbdmd.com | 2015 | Charlotte, United States | 52 | Cannabis products are offered via an online retail platform. |
Detailed competitors of Demetrix
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Cannabis Health Tech Ecosystem
3 companies that operate in the same segment as Demetrix (Cannabis Health Tech Ecosystem) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Online marketplace platform for cannabis traders | 2015 | New York, New York, United States | USD 195.4 M | |||
Loyalty and marketing solutions for cannabis dispensaries are provided. | 2012 | West Palm Beach, Florida, United States | USD 25.79 M | USD 22.83 M | ||
An online marketplace for cannabis products is operated. | 2017 | Bend, Oregon, United States | USD 603 M | 469 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Demetrix
Complete news archive for Demetrix
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Demetrix
Demetrix was founded in 2017 and raised its 1st funding round 1 year after it was founded.
Demetrix is headquartered in Berkeley, United States. It is registered at Berkeley, California, United States.
Jeff Ubersax is the CEO of Demetrix, as recorded in our data.
Demetrix is a funded company, having raised a total of $61M across 2 funding rounds to date. The company's 1st funding round was a Seed of $11M, raised on Jan 2018.
Demetrix has 77 employees.
Demetrix was founded in 2017 in Berkeley, United States, and operates within the biotechnology sector focused on cannabinoids. Rare, high-purity cannabinoid ingredients are developed and commercialized using fermentation technology for pharmaceutical and consumer health applications. Production processes are regulated to ensure compliance, with emphasis placed on wellness products derived from these ingredients. Operations are centered in the United States, supporting global commercialization efforts.
Demetrix's top competitors include Vireo Health, cbdMD and Shopbeam.
Demetrix has 3 investors. Key investors include Tuatara Capital, Horizons Ventures, and Li Ka-shing.
Demetrix operates through Demetrix, Inc..